• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Zynerba Pharma CS (NQ: ZYNE )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Oct 10, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open -
    Bid (Size) 1.300 (10)
    Ask (Size) 1.370 (10)
    Prev. Close 1.300
    Today's Range N/A - N/A
    52wk Range N/A - N/A
    Shares Outstanding 53,939,431
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why Shares of Harmony Bioscience Are Falling on Friday
    The company reported underwhelming phase 3 trial results for Pitolisant to treat idiopathic hypersomnia. 
    Via The Motley Fool
    New Possibilities For Cannabinoid Treatments: Acquisition To Transform Neuropsychiatric Disorder Therapies
    Healthcare company Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) completed its previously announced acquisition of Zynerba Pharmaceuticals, Inc. 
    Via Benzinga

    Performance

    More News

    Read More
    Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and Instructions
    From Zynerba Pharmaceuticals, Inc.
    Via GlobeNewswire
    Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023
    From Zynerba Pharmaceuticals, Inc.
    Via GlobeNewswire
    Bearish Sentiment Across The Cannabis Space - Check Full Movers For September 26, 2023
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Cannabis Stock Movers For September 18, 2023
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q11.2 Deletion Syndrome at The Society for the Study of Behavioural Phenotypes (SSBP) 25th International Research Symposium
    From Zynerba Pharmaceuticals, Inc.
    Via GlobeNewswire
    ZYNERBA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Zynerba Pharmaceuticals, Inc. - ZYNE
    From Kahn Swick & Foti, LLC
    Via Business Wire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sovos Brands, Inc. (Nasdaq - SOVO), Zynerba Pharmaceuticals, Inc. (Nasdaq - ZYNE), Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc.
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Cannabis Stock Movers For August 18, 2023
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2023
    Via Benzinga
    Cannabis Stock Gainers And Losers From August 16, 2023
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Occidental Petroleum To Rally Around 18%? Here Are 10 Other Analyst Forecasts For Wednesday
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023
    Via Benzinga
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Zynerba Pharmaceuticals, Inc. (Nasdaq - ZYNE), Chindata Group Holdings Limited (Nasdaq - CD), Capri Holdings Limited (NYSE – CPRI), Avid® (Nasdaq - AVID)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Cannabis Stock Gainers And Losers From August 14, 2023
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Crude Oil Down 1%; Zynerba Pharmaceuticals Shares Spike Higher
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why Is Zynerba Pharmaceuticals (ZYNE) Stock Up 270% Today?
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    US Stocks Turn Higher; BioXcel Therapeutics Shares Plummet
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Health Care Company Harmony Biosciences Announces Acquisition of Zynerba Pharmaceuticals
    Via Benzinga
    Why Zynerba Pharmaceuticals Stock Is Skyrocketing Today?
    Via Benzinga
    Dow Falls 50 Points; Monday.com Posts Upbeat Results
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.